Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI

Clinical trial NCT02901717 · UNKNOWN

Trial details

NCT number: NCT02901717
Sponsor: Leonard-Meron Biosciences, Inc.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Catheter-related Infections

Start date: 2018-02-13
Primary completion: 2022-12-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.